TG THERAPEUTICS INC (TGTX)

US88322Q1085 - Common Stock

28.88  +0.11 (+0.38%)

After market: 28.6 -0.28 (-0.97%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-14.36M12.67M-198.34M-348.10M-279.38M
Depreciation Amortization
100.00K211.00K300.00K280.00K160.00K
Change In Working Capital
-56.40M-84.45M-1.44M-12.00M-19.54M
Interest Paid
14.48M8.77M5.45M3.47M4.50M
Other non cash items
42.57M40.15M23.30M64.19M84.26M
OPERATING CASH FLOW
-28.09M-31.41M-176.17M-295.63M-214.51M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
N/A0.00-10.00K-400.00K-360.00K
Other Investing Activity
-61.55M-50.65M-20.00M70.00K-24.15M
INVESTING CASH FLOW
-61.58M-50.65M-20.01M-330.00K-24.51M
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
137.26M25.00M-980.00K40.00M0.00
Stock Issued/Repurchased
-1.80M47.83M580.00K2.44M679.83M
Other Financing Activity
-853.00K-125.00K0.00-1.02M0.00
FINANCING CASH FLOW
134.59M72.70M-390.00K41.42M679.83M
 
CHANGE IN CASH
44.93M-9.36M-196.57M-254.54M440.81M
 
FREE CASH FLOW
Operating Cash Flow
-28.09M-31.41M-176.17M-295.63M-214.51M
Capital Expenditure
N/A0.00-10.00K-400.00K-360.00K
FREE CASH FLOW
-28.11M-31.41M-176.18M-296.03M-214.87M

All data in USD

Charts